| Filed On | Filing |
|---|---|
| 16 Oct 2026 |
Proxy statement: annual meeting on December 11, 2026
CEO pay $285K, up 42% · say-on-pay vote |
| 15 Oct 2026 | 10-Q |
| 15 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
On October 12, 2026, David Moatazedi, a member of the Board of Directors (the “Board”) of Biomerica, Inc. (the “Company”), communicated to the Board that he has determined not to stand for re-election to the Board at the Company’s 2026 A... |
| 07 Oct 2026 | EFFECT |
| 07 Oct 2026 | EFFECT |
| 28 Sep 2026 | 10-K/A |
| 24 Sep 2026 | S-3 |
| 24 Sep 2026 | S-3 |
| 10 Sep 2026 |
Form 3: Brc Group Holdings, Inc., 10% owner and 2 others
Holds 460,080 shares of Common Stock, $0.08 par value per share |
| 08 Sep 2026 | Form 3: Qu Xiaoxuan, See Remarks |
| 31 Aug 2026 | 10-K |
| 28 Aug 2026 | SCHEDULE 13D |
| 27 Aug 2026 |
Form 4: Gary M. Huff, Director
Bought 31,250 shares ($50K) |
| 27 Aug 2026 |
Form 4: Moatazedi David, Director
Bought 10,000 shares ($16K) |
| 27 Aug 2026 |
Form 4: Chin Eric, Director
Bought 6,250 shares ($10K) |
| 27 Aug 2026 |
Form 4: Barbieri Allen, Director
Bought 20,000 shares ($32K) |
| 27 Aug 2026 |
Form 4: Irani Zackary S., Director
Bought 31,250 shares ($50K) |
| 26 Aug 2026 | 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities |
| 04 Jun 2026 | 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation |
| 13 Apr 2026 | 10-Q |
Loading...
